Search results for "Enzyme-linked immunosorbent assay"

showing 10 items of 491 documents

Gliadin, zonulin and gut permeabilità: effects on celiac and non-celiac intestinal mucosa and intestinal cell lines.

2006

Objective. Little is known about the interaction of gliadin with intestinal epithelial cells and the mechanism(s) through which gliadin crosses the intestinal epithelial barrier. We investigated whether gliadin has any immediate effect on zonulin release and signaling. Material and methods. Both ex vivo human small intestines and intestinal cell monolayers were exposed to gliadin, and zonulin release and changes in paracellular permeability were monitored in the presence and absence of zonulin antagonism. Zonulin binding, cytoskeletal rearrangement, and zonula occludens-1 (ZO-1) redistribution were evaluated by immunofluorescence microscopy. Tight junction occludin and ZO-1 gene expression …

Cholera ToxinGene ExpressionEnzyme-Linked Immunosorbent AssayOccludindigestive systemCoeliac diseaseGliadinPermeabilityTight JunctionsIntestinal mucosaOccludinIntestine SmallmedicineAnimalsHumansIntestinal MucosaProtein PrecursorsCells CulturedIntestinal permeabilitybiologyTight junctionHaptoglobinsGastroenterologynutritional and metabolic diseasesZonulinMembrane ProteinsEpithelial Cellsmedicine.diseasePhosphoproteinsMolecular biologydigestive system diseasesRatsCeliac DiseaseMicroscopy FluorescenceParacellular transportImmunologybiology.proteinZonula Occludens-1 ProteinGliadin
researchProduct

THE RECOVERY-ELISA—A NOVEL ASSAY TECHNIQUE TO MONITOR THERAPY WITH HUMANIZED ANTIBODIES: THE EXAMPLE OF OMALIZUMAB

2013

The therapeutic use of antibodies has grown exponentially, providing new treatment options for various diseases. Monitoring treatment with therapeutic antibodies is a particular challenge because often the target antigen is no longer measurable or the results are unreliable. To overcome this problem, a recovery-ELISA was developed to quantify therapeutic antibody and antigen by a modification of the traditional sandwich immunoassay using omalizumab as an example. Standard serum samples were spiked with IgE and omalizumab in a certain concentration range to create standard curves. After incubation and washout procedures, the reaction was stopped and the plate read with bichromatic absorbance…

Clinical BiochemistryImmunologyEnzyme-Linked Immunosorbent AssayOmalizumabOmalizumabPharmacologyAntibodies Monoclonal HumanizedImmunoglobulin EAntigenmedicineHumansImmunology and Allergybiologybusiness.industryAntibodies MonoclonalImmunoglobulin ESerum samplesAssay techniqueAntibodies Anti-IdiotypicStandard curveMedical Laboratory TechnologyTherapeutic antibodyImmunologybiology.proteinDrug MonitoringAntibodybusinessmedicine.drugJournal of Immunoassay and Immunochemistry
researchProduct

Precise mapping of the Goodpasture epitope(s) using phage display, site-directed mutagenesis, and surface plasmon resonance.

2013

Goodpasture disease is an autoimmune disorder mediated by circulating autoantibodies against the noncollagenous-1 (NC1) domain of the alpha 3 chain of type IV collagen (alpha 3(IV)NC1). The structure of Goodpasture epitope(s) has been previously mapped into two main binding regions (E-A and E-B) of the alpha 3(IV)NC1 domain using a residue mutation approach on the highly related alpha 1(IV)NC1 domain. Here we combined phage display and surface plasmon resonance technology to more precisely localize the pathogenic binding sites. Peptides mimicking the Goodpasture epitope(s) were used to identify residues involved in autoantibody binding and found involvement of eight residues previously unre…

Collagen Type IVMalePhage displayautoantibodiesMutantMutagenesis (molecular biology technique)Enzyme-Linked Immunosorbent Assaycollagen type IVAutoantigensEpitopeType IV collagenHumansBinding siteSite-directed mutagenesisAutoantibodiesepitopeChemistryAutoantibodyGoodpasture diseaseMiddle AgedSurface Plasmon ResonanceMolecular biologyNephrologyMutagenesis Site-DirectedBinding Sites Antibodyphage displayCell Surface Display Techniquessurface plasmon resonanceEpitope MappingKidney international
researchProduct

Enzymatic alteration of C1q, the collagen-like subcomponent of the first component of complement, leads to cross-reactivity with type II collagen

1988

AbstractNative serum C1q, the collagenous-like subcomponent of the first component of complement, is not recognized by polyclonal anti-collagen type II antibodies. However, when purified C1q was subjected to limited proteolysis by collagenase it showed antigenic cross-reactivity with collagen type II. The same cross-reactivity was observed with hemolytically active C1q in synovial fluids of patients with rheumatoid arthritis (RA), whereas C1q from synovial fluids of patients with osteoarthritis (OA), villo-nodular synovitis and ankylosing spondylitis was not recognized by this antibody. However, incubation of synovial fluid C1q of OA patients with synovial fluid leucocytes from RA patients …

Complement Activating EnzymesCollagenaseComplementBiophysicsType II collagenEnzyme-Linked Immunosorbent Assaychemical and pharmacologic phenomenaOsteoarthritisBiochemistryAntibodiesArthritis Rheumatoidfluids and secretionsAntigenComplement C1immune system diseasesStructural BiologySynovitisOsteoarthritisSynovial FluidGeneticsmedicineAnimalsHumansSynovial fluidSpondylitis AnkylosingAntigensRheumatoid arthritisskin and connective tissue diseasesMolecular BiologyC1qAutoantibodiesSheepSynovitisbiologyChemistryComplement C1qAntibodies MonoclonalCell Biologymedicine.diseaseMolecular biologyMicrobial CollagenasePolyclonal antibodiesImmunologyCollagenasebiology.proteinCollagenAntibodyGranulocytesmedicine.drugFEBS Letters
researchProduct

Evidence for the presence of autoantibodies to the collagen-like portion of C1q in systemic lupus erythematosus.

1988

We investigated the connection between the C1q solid-phase binding assay (C1q SPBA) and double-stranded DNA antibodies, and analyzed the immune complex material in systemic lupus erythematosus (SLE) sera. Comparison with a new monoclonal assay for C1q-bearing immune complexes (the 242G3 assay) revealed that the immune complexes in SLE bind specifically to solid-phase C1q, and not to fluid-phase C1q. The C1q solid-phase binding activity sedimented as 7S IgG, was insensitive to DNase treatment, and could be selectively absorbed by C1q-coupled beads and by bovine serum albumin-anti-bovine serum albumin C1q beads, but not by DNA. Thus, antibodies to double-stranded DNA do not interfere in the C…

Complement Activating EnzymesImmunologySerum albuminchemical and pharmacologic phenomenaEnzyme-Linked Immunosorbent AssayAntigen-Antibody Complexurologic and male genital diseasesfluids and secretionsImmune systemRheumatologyimmune system diseasesComplement C1medicineImmunology and AllergyHumansLupus Erythematosus SystemicPharmacology (medical)Bovine serum albuminskin and connective tissue diseasesAutoantibodiesLupus erythematosusbiologybusiness.industryLigand binding assayComplement C1qAutoantibodyDNA Neoplasmmedicine.diseaseImmune complexImmunoglobulin GImmunologybiology.proteinCollagenAntibodybusinessUltracentrifugationArthritis and rheumatism
researchProduct

Nanomaterials and new biorecognition molecules based surface plasmon resonance biosensors for mycotoxin detection

2019

Mycotoxins are highly toxic secondary metabolites, which may contaminate many types of food and feeds. These toxins have serious health risks for both human and animals. One of the effective ways to prevent food contamination and protect people against mycotoxins is based on timely detection. Several methods like enzyme-linked immunosorbent assay and affinity chromatography are commercially available for this purpose. Nevertheless, sensitive, fast, simple, low-cost, and portable devices are absolutely required for a fast point-of care information and making decisions. Application of biosensors appears to be a possible technique to meet this need for mycotoxins analyze. The present study has…

Computer scienceBiomedical EngineeringBiophysicsEnzyme-Linked Immunosorbent AssayFood ContaminationNanotechnologyBiosensing Techniques02 engineering and technology01 natural sciencesChromatography Affinitychemistry.chemical_compoundElectrochemistryHumansSurface plasmon resonanceMycotoxin010401 analytical chemistrytechnology industry and agricultureGeneral MedicineMycotoxinsSurface Plasmon Resonance021001 nanoscience & nanotechnologyNanostructures0104 chemical sciencesSignal enhancementchemistryEnvironmental Pollutants0210 nano-technologyBiosensorBiotechnologyBiosensors and Bioelectronics
researchProduct

Activation of the human immune system via toll-like receptors by the oncolytic parvovirus H-1.

2012

This study aimed to investigate the function of toll-like receptors (TLRs) during oncolytic parvovirus H-1 (H-1PV)-induced human immune responses. First, the role of TLRs in the activation of the NFκB transcription factor was characterized; second, the immunologic effects of H-1PV-induced tumor cell lysates (TCL) on human antitumor immune responses were evaluated. A human ex vivo model was used to study immune responses with dendritic cells (DCs). Human embryonic kidney cells (HEK293) transfected to stably express TLRs were used as potential human DC equivalents to further investigate the role of specific TLRs during immune activation. TLR3 and TLR9 were activated by H-1PV infection, which …

Cytotoxicity ImmunologicH-1 parvovirusCancer ResearchCytoplasmParvovirus H-1chemical and pharmacologic phenomenaEnzyme-Linked Immunosorbent AssayBiologyKidneyProinflammatory cytokineParvoviridae InfectionsImmune systemTumor Cells CulturedHumansMelanomaCells CulturedCell NucleusOncolytic VirotherapyTumor Necrosis Factor-alphaToll-Like ReceptorsNF-kappa BDendritic CellsAcquired immune systemFlow CytometryCell biologyOncolytic virusOncolytic VirusesOncologyImmune SystemImmunologyTLR3CytokinesTumor necrosis factor alphaSignal transductionSignal TransductionInternational journal of cancer
researchProduct

The occurrence of serological H-Y antigen (Sxs antigen) in the diandric protogynous wrasse, Coris julis (L.) (Labridae, Teleostei)

1987

Abstract The serological sex-specific (Sxs) antigen (previously called ‘H-Y antigen’) has been shown, in various vertebrate species ranging from fish to mammals, to be characteristic of the heterogametic sex. We studied a protogynous hermaphrodite, Coris julis , in order to examine whether the change of a female to a secondary male also involves a change in the Sxs-antigen phenotype. The (homogametic) females of this species were found to be Sxs negative, while both primary and secondary males were Sxs positive. This was true not only for gonads but also for nongo-nadal tissues. The administration of androgen to females is known to cause sex inversion in this species; we were able to demons…

Cytotoxicity ImmunologicMaleCancer Researchmedicine.drug_classH-Y AntigenCorisZoologyEnzyme-Linked Immunosorbent AssayBiologyAntigenHermaphroditeTestismedicineAnimalsTestosteroneMolecular BiologyDrug ImplantsH-Y antigenOvaryFishesCell BiologyAnatomySex reversalAndrogenbiology.organism_classificationSpermatogoniaWrasseOocytesFemaleHeterogametic sexDevelopmental BiologyDifferentiation
researchProduct

Are the leukocyte telomere length attrition and telomerase activity alteration potential predictor biomarkers for sporadic TAA in aged individuals?

2014

A large variability in occurrence, complications, and age/gender manifestations characterizes individual susceptibility of sporadic thoracic aortic aneurysms (TAA), even in subjects with the same risk factor profiles. The reasons are poorly understood. On the other hand, TAA pathophysiology mechanisms remain unclear than those involved in abdominal aorta aneurysms. However, recent evidence is suggesting a crucial role of biological ageing in inter-individual risk variation of cardiovascular diseases, including sporadic TAA. Biological age rather than chronological age is a better predictor of vascular risk. Relevant assumptions support this concept. In confirming this evidence and our preli…

DNA ReplicationMaleTelomerasePathologymedicine.medical_specialtyAgingGenotypeEnzyme-Linked Immunosorbent AssayBiologyPolymerase Chain ReactionArticleAortic aneurysmRisk FactorsGenotypemedicineIn Situ Nick-End LabelingLeukocytesSporadic TAA. Biological ageing . Leukocyte telomere length attrition . Telomere activity alteration . Predictor TAAbiomarkersSettore MED/05 - Patologia ClinicaHumansGenetic Predisposition to DiseaseRisk factorTelomere ShorteningSettore MED/04 - Patologia GeneraleAortic Aneurysm ThoracicSettore MED/23 - Chirurgia CardiacaGeneral MedicineDNAMiddle AgedTelomeremedicine.diseaseMolecular medicineImmunohistochemistryPathophysiologyTelomereAgeingImmunologyFemaleGeriatrics and GerontologyBiomarkersAge (Dordrecht, Netherlands)
researchProduct

Identification of target antigen for SLA/LP autoantibodies in autoimmune hepatitis.

2000

Summary Background Autoantibodies are a hallmark of autoimmune hepatitis, but most are not disease specific. Autoantibodies to soluble liver antigen (SLA) and to liver and pancreas antigen (LP) have been described as disease specific, occurring in about 30% of all patients with autoimmune hepatitis, but no standardised assays are available. Methods We tested 2000 serum samples from patients with various liver diseases and controls for SLA autoantibodies by inhibition ELISA. Serum samples positive for SLA antibodies were used for immunoscreening of cDNA expression libraries. Identified clones were tested against a panel of serum samples positive for SLA and LP autoantibodies and control seru…

DNA ComplementaryBlotting WesternMolecular Sequence DataSequence HomologyEnzyme-Linked Immunosorbent AssayAutoimmune hepatitisBiologyAutoantigensEpitopeEpitopesPrimary biliary cirrhosisAntigenmedicineHumansLymphocytesPancreasAutoantibodiesAutoimmune diseaseHepatitisBase SequencefungiAutoantibodyGeneral Medicinemedicine.diseaseVirologyHepatitis AutoimmuneLiverImmunologybiology.proteinAntibodyLancet (London, England)
researchProduct